Microarray Innovations in LEukemia (MILE) study: Stage 1 data
An International Multi-Center Study to Define the Clinical Utility of Microarray–Based Gene Expression Profiling in the Diagnosis and Sub-classification of Leukemia (MILE Study) Established in 2005, the MILE (Microarray Innovations in LEukemia) study research program included 11 participating centers in three continents. This cohort of n=2,096 samples represents data on the retrospective whole-genome analysis phase. This dataset is part of the MILE Study (Microarray Innovations In LEukemia) pr...
Provenance — who produced it, who reused it
Linked to 65 papers in the literature. Roles are inferred factual signals (who deposited the data vs who reused it), with counts — never a judgement about any author.
- Targeting the RNA m6A Reader YTHDF2 Selectively Compromises Canc... 2019 · 552 cites
- RNA Demethylase ALKBH5 Selectively Promotes Tumorigenesis and Ca... 2020 · 380 cites
- Integrating Proteomics and Transcriptomics for Systematic Combin... 2017 · 346 cites
- PRMT1-mediated FLT3 arginine methylation promotes maintenance of... 2019 · 93 cites
- Reactive Oxygen Species Drive Proliferation in Acute Myeloid Leu... 2019 · 90 cites
- Selective inhibition of Ph-positive ALL cell growth through kina... 2020 · 89 cites
- RBFOX2 recognizes N6-methyladenosine to suppress transcription a... 2023 · 86 cites
- Cytoplasmic NEAT1 Suppresses AML Stem Cell Self‐Renewal and Leuk... 2021 · 83 cites
- SHQ1 regulation of RNA splicing is required for T-lymphoblastic... 2018 · 79 cites
56 further papers cite this accession but reuse could not be confirmed.
Deep data QC
metadata only · no data-level QC for this typeStandardized, field-standard QC computed by touching the data — every metric states how it was obtained
measured = computed from the data · extrapolated/reported = derived or from the repository · dq-1.0 · provisional — verify independently